Humalog is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Lispro.
| Product ID | 50090-1375_6dbd4601-3133-4f0f-a77b-b1d9b37b40c2 |
| NDC | 50090-1375 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Humalog |
| Generic Name | Insulin Lispro |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 1996-06-14 |
| Marketing Category | BLA / NDA |
| Application Number | BLA020563 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | INSULIN LISPRO |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020563 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-05-31 |
| Ingredient | Strength |
|---|---|
| INSULIN LISPRO | 100 [iU]/mL |
| SPL SET ID: | c6b8ff07-d3e2-457f-8a38-b60de60adf75 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0002-7510 | Humalog | Insulin lispro |
| 0002-7511 | Humalog | Insulin lispro |
| 0002-7512 | Humalog | Insulin lispro |
| 0002-7516 | Humalog | Insulin lispro |
| 0002-7712 | Humalog | Insulin lispro |
| 0002-7714 | Humalog | Insulin lispro |
| 70518-1388 | Humalog | Humalog |
| 50090-1375 | Humalog | Humalog |
| 55045-3602 | Humalog | Humalog |
| 50090-4488 | Humalog | Humalog |
| 70518-2264 | Humalog | Humalog |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HUMALOG 74314093 1963572 Live/Registered |
Eli Lilly and Company 1992-09-15 |